Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giulia De Angelis

Showing results (91-100 of 111) with videos related to

Pageof 12
Sort By:
Infection and Drug Resistance|May 24, 2019
Direct use of eazyplex<sup>®</sup> SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> bloodstream infectionsBarbara Fiori, Tiziana D'Inzeo, Brunella Posteraro, et al.
Genome Medicine|December 20, 2024
Tracing carriage, acquisition, and transmission of ESBL-producing Escherichia coli over two years in a tertiary care hospitalMinh Ngoc Nguyen, Beryl Primrose Gladstone, Giulia De Angelis, et al.
Scientific Reports|July 21, 2025
Pseudomonas aeruginosa carriage and associated risk factors in healthy individuals and patients from Rotterdam, Rome, and JakartaAnneloes van Veen, Selvi N Shahab, Amber Rijfkogel, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2009
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based studyEvelina Tacconelli, Giulia De Angelis, Maria Adriana Cataldo, et al.
Critical Care (London, England)|June 8, 2021
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosisGennaro De Pascale, Flavio De Maio, Simone Carelli, et al.
Mycoses|June 13, 2020
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxisBrunella Posteraro, Elena De Carolis, Marianna Criscuolo, et al.
The Journal of Infectious Diseases|October 16, 2025
The Care Continuum of Patients With Influenza in the Post-COVID-19 Era: A Position PaperStamatis Karakonstantis, Theodore Lytras, Siran Keske, et al.
Critical Care (London, England)|September 6, 2020
(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trialGennaro De Pascale, Brunella Posteraro, Sonia D'Arrigo, et al.
Antibiotics (Basel, Switzerland)|August 26, 2022
In Vitro Activity of Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates: A Multicentre Report from ItalyBernardetta Segatore, Alessandra Piccirilli, Sabrina Cherubini, et al.
JACC. Clinical Electrophysiology|May 25, 2024
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization TherapyMatteo Dal Ferro, Alessia Paldino, Caterina Gregorio, et al.
Pageof 12

Showing results (91-100 of 111) with videos related to

Sort By:
Pageof 12
Infection and Drug Resistance|May 24, 2019
Direct use of eazyplex<sup>®</sup> SuperBug CRE assay from positive blood cultures in conjunction with inpatient infectious disease consulting for timely appropriate antimicrobial therapy in <i>Escherichia coli</i> and <i>Klebsiella pneumoniae</i> bloodstream infectionsBarbara Fiori, Tiziana D'Inzeo, Brunella Posteraro, et al.
Genome Medicine|December 20, 2024
Tracing carriage, acquisition, and transmission of ESBL-producing Escherichia coli over two years in a tertiary care hospitalMinh Ngoc Nguyen, Beryl Primrose Gladstone, Giulia De Angelis, et al.
Scientific Reports|July 21, 2025
Pseudomonas aeruginosa carriage and associated risk factors in healthy individuals and patients from Rotterdam, Rome, and JakartaAnneloes van Veen, Selvi N Shahab, Amber Rijfkogel, et al.
Antimicrobial Agents and Chemotherapy|August 12, 2009
Antibiotic usage and risk of colonization and infection with antibiotic-resistant bacteria: a hospital population-based studyEvelina Tacconelli, Giulia De Angelis, Maria Adriana Cataldo, et al.
Critical Care (London, England)|June 8, 2021
Staphylococcus aureus ventilator-associated pneumonia in patients with COVID-19: clinical features and potential inference with lung dysbiosisGennaro De Pascale, Flavio De Maio, Simone Carelli, et al.
Mycoses|June 13, 2020
Candidaemia in haematological malignancy patients from a SEIFEM study: Epidemiological patterns according to antifungal prophylaxisBrunella Posteraro, Elena De Carolis, Marianna Criscuolo, et al.
The Journal of Infectious Diseases|October 16, 2025
The Care Continuum of Patients With Influenza in the Post-COVID-19 Era: A Position PaperStamatis Karakonstantis, Theodore Lytras, Siran Keske, et al.
Critical Care (London, England)|September 6, 2020
(1,3)-β-D-Glucan-based empirical antifungal interruption in suspected invasive candidiasis: a randomized trialGennaro De Pascale, Brunella Posteraro, Sonia D'Arrigo, et al.
Antibiotics (Basel, Switzerland)|August 26, 2022
In Vitro Activity of Sulbactam-Durlobactam against Carbapenem-Resistant <i>Acinetobacter baumannii</i> Clinical Isolates: A Multicentre Report from ItalyBernardetta Segatore, Alessandra Piccirilli, Sabrina Cherubini, et al.
JACC. Clinical Electrophysiology|May 25, 2024
Impact of DCM-Causing Genetic Background on Long-Term Response to Cardiac Resynchronization TherapyMatteo Dal Ferro, Alessia Paldino, Caterina Gregorio, et al.
Pageof 12